Novel Three-Drug Regimen for Extensively Drug-Resistant Tuberculosis
Novel Three-Drug Regimen for Extensively Drug-Resistant Tuberculosis
About this item
Full title
Novel Three-Drug Regimen for Extensively Drug-Resistant Tuberculosis
Author / Creator
Publisher
Waltham: Massachusetts Medical Society
Journal title
NEJM journal watch. Infectious diseases, 2020-03
Language
English
Formats
Publication information
Publisher
Waltham: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
A 26-week oral regimen of bedaquiline, pretomanid, and linezolid was 90% effective in treating patients with XDR-TB.
Alternative Titles
Full title
Novel Three-Drug Regimen for Extensively Drug-Resistant Tuberculosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2371067561
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2371067561
Other Identifiers
ISSN
2330-040X
How to access this item
Log in as a Library member
